Seeking Alpha

jjjorgen

jjjorgen
Send Message
View as an RSS Feed
View jjjorgen's Comments BY TICKER:
Latest  |  Highest rated
  • Amicus Therapeutics - Long Opportunity With Asymmetric Upside Potential And Near-Term Catalyst [View article]
    Another large purchase eod on Friday. My gut is starting to tell me something is up.
    Jun 28, 2014. 09:26 AM | Likes Like |Link to Comment
  • Amicus Therapeutics - Long Opportunity With Asymmetric Upside Potential And Near-Term Catalyst [View article]
    Not a bad article for a first SA article! I'm Long, thanks for the write-up!
    Jun 27, 2014. 11:00 AM | 1 Like Like |Link to Comment
  • 7 Reasons To Buy This Stock With A 7 Handle [View article]
    Unfortunately, no. Sold quite a while back. Good luck to everyone still long!
    Jun 15, 2014. 10:04 AM | Likes Like |Link to Comment
  • Amicus Therapeutics Still A "Show Me" Story [View article]
    I see you fail to mention Hedge Fund Perceptive Advisors took a 13% stake in the company on June 3rd. They do not make investments without a strong conviction of success or failure. In Amicus, they are looking for success. This is the time to accumulate, imo.
    Jun 12, 2014. 02:22 PM | Likes Like |Link to Comment
  • Notes From One-On-One Meetings During San Fran Biotech Week - Day 3 [View article]
    Thoughts on CYNAF now?
    Apr 9, 2014. 04:48 PM | 1 Like Like |Link to Comment
  • Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease [View article]
    Happy for you, Mane, now load up on shares!
    Apr 9, 2014. 09:52 AM | 1 Like Like |Link to Comment
  • Target's long lines get dissected [View news story]
    Definitely don't agree with this opinion. I shop at Target quite frequently, and they always add cashier's if lines start growing. I do see this tactic at WalMart and a few other retailers.
    Apr 8, 2014. 08:19 AM | 3 Likes Like |Link to Comment
  • Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So [View article]
    Opinions are varying here, depending if you are long or short on the stock. IMO, very scary position to be in this short. Probability very high for approval, then almost surely we will partner or be purchased. My bet is we are purchased. I could spell out the analysis on this, but if you own the stock, you already know the reasons why. Next few weeks will be interesting!
    Apr 6, 2014. 09:31 AM | 2 Likes Like |Link to Comment
  • How MannKind Shows Depth Of The Diabetes Market [View article]
    The replies here are 1000 times better than the article! Partnership or sale of the company soon, it's just a given!
    Apr 4, 2014. 09:20 AM | 1 Like Like |Link to Comment
  • A Picture Is Worth A Thousand Words: Implications From Sovaldi Treatment Trends [View article]
    Roneth, please explain why??
    Mar 24, 2014. 05:09 PM | Likes Like |Link to Comment
  • Gilead Is An Avoid [View article]
    I feel Gilead has the upper hand on patent disputes. Check out this release for Idenix this morning:

    http://bit.ly/1iu0VSl
    Mar 24, 2014. 08:43 AM | Likes Like |Link to Comment
  • Gilead Is An Avoid [View article]
    When's the last time Australia developed a blockbuster drug, and sold it for a minimal price like everyone wants? They won't, and financially can't! I hate to say it, But big Pharma thrives here, and new drugs are developed daily, almost ONLY because of the payoff in the end. It's called "Capitalism" The rest of the world gets the benefits of our efforts. Be thankful the U.S. is designed as it is...
    Mar 23, 2014. 09:41 AM | 4 Likes Like |Link to Comment
  • Gilead Is An Avoid [View article]
    Exactly my feelings! If your a short-term trader, fine, get out. Gilead is rich with future potential, as well as current earnings. And scrips continue to increase, they are just not going to stop. People want to be cured. With Sovaldi earnings, Gilead will also be investing into new drugs of the future. Think Forward! Also, Sovaldi is only one piece of the current prize.
    Mar 21, 2014. 03:42 PM | 4 Likes Like |Link to Comment
  • Gilead Is An Avoid [View article]
    Wow, what an analysis (NOT!). Gilead is at a BUY position currently.
    Mar 21, 2014. 02:16 PM | 16 Likes Like |Link to Comment
  • A Comprehensive Look At Athersys [View article]
    11137741~ Nice rebuttal! Looking forward to Thursday afternoon's call!
    Mar 9, 2014. 05:15 PM | 1 Like Like |Link to Comment
COMMENTS STATS
325 Comments
242 Likes